{
    "Trade/Device Name(s)": [
        "BioPlex 2200 Vasculitis kit",
        "BioPlex 2200 Vasculitis Calibrator Set",
        "BioPlex 2200 Vasculitis Control Set"
    ],
    "Submitter Information": "Bio-Rad Laboratories, Inc.",
    "510(k) Number": "K072358",
    "Predicate Device Reference 510(k) Number(s)": [
        "K041040",
        "K041043",
        "K984336",
        "K961340"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MOB",
        "MVJ",
        "JIX",
        "JJY"
    ],
    "Summary Letter Date": "October 31, 2007",
    "Summary Letter Received Date": "August 22, 2007",
    "Submission Date": "August 20, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.5660"
    ],
    "Regulation Name(s)": [
        "Multiple Autoantibodies Immunological Test System"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "Myeloperoxidase (MPO)",
        "Proteinase 3 (PR3)",
        "Glomerular Basement Membrane (GBM)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BioPlex 2200 System",
        "BioPlex 2200 Multi-Analyte Detection System"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex flow immunoassay"
    ],
    "Methodologies": [
        "Multiplex bead-based immunoassay",
        "Semi-quantitative detection"
    ],
    "Submission Type(s)": [
        "Kit",
        "Calibrator",
        "Control",
        "Reagent Pack",
        "Instrument",
        "System",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for BioPlex 2200 Vasculitis kit, calibrator, and control sets using multiplex flow immunoassay for detection of IgG autoantibodies to MPO, PR3, and GBM in human serum on BioPlex 2200 platform",
    "Indications for Use Summary": "Aids in the semi-quantitative detection of IgG autoantibodies to MPO, PR3, and GBM in human serum as an aid in diagnosing certain autoimmune vasculitides and renal disorders, used with the BioPlex 2200 System and clinical assessment",
    "fda_folder": "Immunology"
}